Cover Image
市場調查報告書

分子診斷、血液捐贈者篩檢的美國市場:2016年 (2022年為止的預測)

US Market for Molecular Diagnostics and Blood Donor Screening - 2016 (Forecasted to 2022)

出版商 iData Research Inc. 商品編碼 344802
出版日期 內容資訊 英文 104 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
分子診斷、血液捐贈者篩檢的美國市場:2016年 (2022年為止的預測) US Market for Molecular Diagnostics and Blood Donor Screening - 2016 (Forecasted to 2022)
出版日期: 2015年10月01日 內容資訊: 英文 104 Pages
簡介

分子診斷,過去只能由受極高訓練的檢驗技師在大規模實驗室實施,不過,由於利用多功能的實行、多化驗的行動的自動系統成為可能,在經驗少的人員可使用的小規模醫院及獨立實驗室中的引進也急速擴展。由於許多小規模競爭企業的進入造成檢驗價格低,與傳統的檢驗方法(微生物學及免疫檢測法等) 比較的分子化驗的高特異性、敏銳度等要素,一般認為分子診斷在今後的美國IVD市場中保持優勢。

本報告提供美國的分子診斷、血液捐贈者篩檢市場相關分析、市場整體結構和近幾年的市場形勢、資本交易趨勢調查、各領域的市場結構和市場規模詳細趨勢估計、考察。

目錄

圖表

第1章 摘要整理

第2章 調查手法

  • 調查範圍
  • IDATA的9階段分析方法

第3章 分子診斷市場

  • 簡介
  • 市場分析、預測
    • 分子診斷設備市場
    • 分子診斷化驗套件市場整體
      • 感染疾病診斷化驗套件市場整體
        • 血液性病毒感染化驗套件市場整體
        • HIV
        • HCV
        • HBV
        • 女性醫療用化驗套件市場整體
        • HPV
        • HSV
        • CT/GC
        • 其他感染疾病化驗套件市場
        • MRSA
        • 難辨梭狀芽孢桿菌
        • CMV
      • 遺傳基因診斷化驗套件市場整體
        • 囊狀纖維化症
        • 易栓症
      • 癌症診斷化驗套件市場整體
        • 乳癌
        • 大腸癌
        • 前列腺癌
  • 市場促進成長要素與阻礙因素
    • 推動因素
    • 阻礙因素
  • 競爭分析

第4章 分子血液捐贈者篩檢市場

  • 簡介
  • 市場分析、預測
    • 分子血液捐贈者篩檢分析儀市場
    • 分子血液捐贈者篩檢化驗套件市場整體
      • WNV
      • HIV
      • HCV
      • HBV
      • 複合檢驗
  • 市場促進成長要素與阻礙因素
    • 推動因素
    • 阻礙因素
  • 競爭分析

簡稱一覽

目錄
Product Code: iDATA_USMDBD16_RPT

The US Molecular Diagnostics and Blood Donor Screening Market report contains Molecular Diagnostics Instrument Market, MDx Assay Kit Market, Infectious Disease Diagnostic Assay Kit Market, Genetic Diagnostics Assay Kit Market, and the Oncology Diagnostics Assay Kit Market. The Blood Donor Screening Market consists of the Molecular Blood Donor Screening Analyzer Market and Assay Kit Market.

The MDx market includes analytical systems and assays used for DNA (and RNA) extraction, amplification and detection. Systems can range from low throughput instruments such as thermal cyclers to high throughput automated systems. They may run on different technologies such as polymerase chain reaction (PCR), transcription mediated amplification (TMA) or gel electrophoresis. Tests may be used for identifying disease, for monitoring disease progression and effects of treatment or for predicting predisposition of individuals to various diseases. Revenues associated with companion diagnostic tests for therapeutic drugs or testing done using technologies such as Fluorescence In Situ Hybridization (FISH) or Next Generation Sequencing (NGS) are not included in this report.

Molecular diagnostics, once confined to large labs with highly trained laboratorians, is rapidly being adopted by smaller hospitals and independent labs with less skilled labor due to the following key factors: availability of automated systems capable of performing multiple functions and running multiple assays on a single platform, decreasing test prices owing to the entry of many smaller competitors, high specificity and sensitivity of molecular assays compared to other traditional testing methods (such as microbiology or immunoassays), and favorable FDA guidelines requiring new drug therapies to be tested for their efficacy on particular patient groups through associated companion diagnostic tests. All these factors will enable molecular diagnostics to continue its dominance in the U.S. IVD market in the future.

While Roche Diagnostics was the clear market leader for 2015 in the Molecular Diagnostics Assay Kit Market, they still were far behind Grifols USA within the Molecular Blood Donor Screening Market. More detailed information on these companies as well as Hologic, Myriad Genetics, Genomic Health, Cephied, Qiagen, Becton Dickinson, Abbott Diagnostics and many more are found in this 2 segment report.

This Report Also Includes:

  • In-depth, Professionally Researched Data That Has Been Formatted and Analyzed to Gain Actionable Insights as Quickly as Possible
  • Executive Summary
  • Trend Analysis by Segment
  • Market Value Forecasts until 2022 and History Back to 2012
  • Market Drivers and Limiters
  • Detailed Competitive Analysis for Each Market and Segment

To Get The Most of this report:

Combine it with our other US market reports on, Hematology, Hemostasis, Molecular Diagnostics, Blood Donor Screening, or Point of Care Diagnostic Devices.

iData Research Methodology - By utilizing a 9-Step Methodology we can ensure that we have the most accurate, up-to-date, and representative figures of the markets. Our data is collected with careful secondary research, and even more importantly our primary research, gathered through interviews and questionnaires with industry professionals, allows us the ability to perform analysis far beyond the initial numbers.

Table of Contents

TABLE OF CONTENTS

LIST OF FIGURES

LIST OF CHARTS

EXECUTIVE SUMMARY

  • 1.1. MOLECULAR DIAGNOSTICS MARKET
  • 1.2. MOLECULAR BLOOD DONOR SCREENING MARKET

RESEARCH METHODOLOGY

  • 2.1. RESEARCH SCOPE
  • 2.2. IDATA'S 9-STEP METHODOLOGY
    • Step 1: Project Initiation & Team Selection
    • Step 2: Prepare Data Systems and Perform Secondary Research
    • Step 3: Preparation for Interviews & Questionnaire Design
    • Step 4: Performing Primary Research
    • Step 5: Research Analysis: Establishing Baseline Estimates
    • Step 6: Market Forecast and Analysis
    • Step 7: Identify Strategic Opportunities
    • Step 8: Final Review and Market Release
    • Step 9: Customer Feedback and Market Monitoring

MOLECULAR DIAGNOSTICS MARKET

  • 3.1. INTRODUCTION
  • 3.2. MARKET ANALYSIS AND FORECAST
    • 3.2.1. Molecular Diagnostics Instrument Market
    • 3.2.2. Total Molecular Diagnostics Assay Kit Market
      • 3.2.2.1. Total Infectious Disease Diagnostic Assay Kit Market
        • 3.2.2.1.1. Total Blood Borne Virus Infectious Disease Assay Kit Market
        • 3.2.2.1.2. HIV Assay Kit Market
        • 3.2.2.1.3. HCV Assay Kit Market
        • 3.2.2.1.4. HBV Assay Kit Market
        • 3.2.2.1.5. Total Women's Health Assay Kit Market
        • 3.2.2.1.6. HPV Assay Kit Market
        • 3.2.2.1.7. HSV Assay Kit Market
        • 3.2.2.1.8. CT/GC Assay Kit Market
        • 3.2.2.1.9. Other Infectious Disease Assay Kit Market
        • 3.2.2.1.10. MRSA Assay Kit Market
        • 3.2.2.1.11. C. difficile Assay Kit Market
        • 3.2.2.1.12. CMV Assay Kit Market
      • 3.2.2.2. Total Genetic Diagnostics Assay Kit Market
        • 3.2.2.2.1. Cystic Fibrosis Assay Kit Market
        • 3.2.2.2.2. 40.2Thrombophilia Assay Kit Market
      • 3.2.2.3. Total Oncology Diagnostics Assay Kit Market
        • 3.2.2.3.1. Breast Cancer Assay Kit Market
        • 3.2.2.3.2. Colorectal Cancer Assay Kit Market
        • 3.2.2.3.3. Prostate Cancer Assay Kit Market
  • 3.3. DRIVERS AND LIMITERS
    • 3.3.1. Market Drivers
    • 3.3.2. Market Limiters
  • 3.4. COMPETITIVE ANALYSIS

MOLECULAR BLOOD DONOR SCREENING MARKET

  • 4.1. INTRODUCTION
  • 4.2. MARKET ANALYSIS AND FORECAST
    • 4.2.1. Molecular Blood Donor Screening Analyzer Market
    • 4.2.2. Total Molecular Blood Donor Screening Assay Kit Market
      • 4.2.2.1. WNV Assay Kit Market
      • 4.2.2.2. HIV Assay Kit Market
      • 4.2.2.3. HCV Assay Kit Market
      • 4.2.2.4. HBV Assay Kit Market
      • 4.2.2.5. Combined Test Assay Kit Market
  • 4.3. DRIVERS AND LIMITERS
    • 4.3.1. Market Drivers
    • 4.3.2. Market Limiters
  • 4.4. COMPETITIVE ANALYSIS

ABBREVIATIONS

Back to Top